Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S - Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial

Anders Perner*, Nicolai Haase, Jørn Wetterslev, Anders Åneman, Jyrki Tenhunen, Anne B. Guttormsen, Gudmundur Klemenzson, Frank Pott, Karen D. Bødker, Per M. Bådstøløkken, Asger Bendtsen, Peter Søe-Jensen, Hamid Tousi, Morten Bestle, Malgorzata Pawlowicz, Robert Winding, Hans Henrik Bülow, Claude Kancir, Morten Steensen, Jonas NielsenBjarne Fogh, Kristian R. Madsen, Nils H. Larsen, Marcela Carlsson, Jørgen Wiis, John A. Petersen, Susanne Iversen, Ole Schøidt, Siv Leivdal, Pawel Berezowicz, Ville Pettilä, Esko Ruokonen, Pål Klepstad, Sari Karlsson, Maija Kaukonen, Juha Rutanen, Sigurbergur Karason, Anne L. Kjældgaard, Lars B. Holst, Jan Wernerman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

52 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S - Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences